General Announcement::Proceedings and Scrutinizer's Report of the 43rd Annual General Meeting

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Sep-2021 23:18:42
Status
New
Announcement Sub Title
Proceedings and Scrutinizer's Report of the 43rd Annual General Meeting
Announcement Reference
SG210924OTHRT584
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
24/09/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Proceedings and Scrutinizer's Report of the 43rd Annual General Meeting (AGM) of Glenmark Pharmaceuticals Limited ('the Company') held on September 24, 2021

Attachments

SGX_Outcome..pdf
Total size =14018K